Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 62,972 | 28,549 | 3,345 | 21,505 | -26,353 |
| Depreciation Amortization | 3,143 | 1,322 | 682 | 5,580 | 4,713 |
| Accounts receivable | 13,396 | 21,469 | 35,941 | -68,893 | -46,712 |
| Other Working Capital | 6,479 | 5,079 | 24,314 | -99,993 | -73,784 |
| Other Operating Activity | 31,333 | 7,272 | -20,679 | 152,526 | 125,281 |
| Operating Cash Flow | $117,323 | $63,691 | $43,603 | $10,725 | $-16,855 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,814 | -1,814 | -1,438 | -6,921 | -4,260 |
| Other Investing Activity | 0 | 0 | 0 | -4,223 | -4,223 |
| Investing Cash Flow | $-1,814 | $-1,814 | $-1,438 | $-11,144 | $-8,483 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 403,174 | 403,174 |
| Debt Repayment | N/A | N/A | N/A | -383,747 | -383,747 |
| Common Stock Issued | 15,022 | 14,352 | 11,955 | 13,595 | 7,148 |
| Common Stock Repurchased | N/A | N/A | N/A | -25,159 | -25,159 |
| Other Financing Activity | 0 | 0 | 0 | -9,048 | -9,048 |
| Financing Cash Flow | $15,022 | $14,352 | $11,955 | $-1,185 | $-7,632 |
| Beginning Cash Position | 179,244 | 179,244 | 179,244 | 180,848 | 180,848 |
| End Cash Position | 309,775 | 255,473 | 233,364 | 179,244 | 147,878 |
| Net Cash Flow | $130,531 | $76,229 | $54,120 | $-1,604 | $-32,970 |
| Free Cash Flow | |||||
| Operating Cash Flow | 117,323 | 63,691 | 43,603 | 10,725 | -16,855 |
| Capital Expenditure | -1,814 | -1,814 | -1,438 | -7,189 | -4,521 |
| Free Cash Flow | 115,509 | 61,877 | 42,165 | 3,536 | -21,376 |